CN Patent
CN101918385A — 二甲氧基多西紫杉醇的结晶形式及其制备方法
Assigned to Aventis Pharma SA · Expires 2010-12-15 · 15y expired
What this patent protects
本发明涉及二甲氧基多西紫杉醇或4-乙酰氧基-2α-苯甲酰氧基-5β,20-环氧-1-羟基-7β,10β-二甲氧基-9-氧代-11-紫杉烯-13α-基醇的(2R,3S)-3-叔丁氧基羰基氨基-2-羟基-3-苯基丙酸酯的酸酐、溶剂化物和乙醇异溶剂化物和水合物的形式,以及它们的制备方法。
USPTO Abstract
本发明涉及二甲氧基多西紫杉醇或4-乙酰氧基-2α-苯甲酰氧基-5β,20-环氧-1-羟基-7β,10β-二甲氧基-9-氧代-11-紫杉烯-13α-基醇的(2R,3S)-3-叔丁氧基羰基氨基-2-羟基-3-苯基丙酸酯的酸酐、溶剂化物和乙醇异溶剂化物和水合物的形式,以及它们的制备方法。
Drugs covered by this patent
- Jevtana Kit (cabazitaxel) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.